News Article

Xencor Receives New Coverage from Analysts at Credit Suisse (XNCR)
Date: Jan 06, 2014
Source: ( click here to go to the source)

Featured firm in this article: Xencor Inc of Monrovia, CA



Xencor Inc logoCredit Suisse initiated coverage on shares of Xencor (NASDAQ:XNCR) in a research note released on Friday morning, TheFlyOnTheWall.com reports. The firm issued an outperform rating and a $14.00 target price on the stock.

Credit Suisse has also updated their ratings on a number of other stocks in the last week. The firm reiterated its neutral rating on shares of China Telecom. Also, Credit Suisse reiterated its outperform rating on shares of China Mobile Ltd..

A number of other analysts have also recently weighed in on XNCR. Analysts at Wedbush initiated coverage on shares of Xencor in a research note to investors on Tuesday, December 31st. They set an outperform rating on the stock. Analysts at Leerink Swann initiated coverage on shares of Xencor in a research note to investors on Monday, December 30th. They set an outperform rating and a $11.00 price target on the stock.

Shares of Xencor (NASDAQ:XNCR) traded up 0.98% on Friday, hitting $9.24. The stock had a trading volume of 16,225 shares. Xencor has a 52 week low of $7.70 and a 52 week high of $10.90. The stock has a 50-day moving average of $8.73 and a 200-day moving average of $8.73. The company's market cap is $271.9 million.

Xencor, Inc (NASDAQ:XNCR) is a clinical-stage biopharmaceutical company.